Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilberto de Castro

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Lancet (London, England)|April 7, 2005
ATAC trial updateGilberto de Castro
Current Opinion in Oncology|March 23, 2006
Management of advanced head and neck squamous cell carcinoma in elderly patientsAhmad Awada, Gilberto de Castro
Current Opinion in Oncology|February 21, 2012
Second primary cancers in head and neck cancer patients: a challenging entityGilberto de Castro, Ahmad Awada
Current Opinion in Oncology|April 7, 2009
Head and neck cancer emerging strategies: advances and new challengesAhmad Awada, Gilberto de Castro
Current Opinion in Oncology|May 25, 2006
Side effects of anti-cancer molecular-targeted therapies (not monoclonal antibodies)Gilberto de Castro, Ahmad Awada
Current Opinion in Oncology|April 9, 2014
The Cancer Genome Atlas findings in head and neck cancer: a renewed hopeGilberto de Castro, Marcelo Vailati Negrão
The Lancet. Oncology|January 4, 2006
Keynote comment: reimbursement for molecularly targeted anticancer agentsUmberto Tirelli, Gilberto de Castro, Ahmad Awada
International Journal of Radiation Oncology, Biology, Physics|March 5, 2013
In reply to OlsonGilberto de Castro, Igor Moisés Longo Snitcovsky
Current Opinion in Oncology|February 24, 2018
Patients' choices, quality of life and treatment selection in head and neck cancerMaria Perez Soares D'Alessandro, Gilberto de Castro
Current Opinion in Oncology|March 23, 2006
Evaluation, prevention and management of radiotherapy-induced xerostomia in head and neck cancer patientsGilberto de Castro, Miriam Hatsue Honda Federico
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Lancet (London, England)|April 7, 2005
ATAC trial updateGilberto de Castro
Current Opinion in Oncology|March 23, 2006
Management of advanced head and neck squamous cell carcinoma in elderly patientsAhmad Awada, Gilberto de Castro
Current Opinion in Oncology|February 21, 2012
Second primary cancers in head and neck cancer patients: a challenging entityGilberto de Castro, Ahmad Awada
Current Opinion in Oncology|April 7, 2009
Head and neck cancer emerging strategies: advances and new challengesAhmad Awada, Gilberto de Castro
Current Opinion in Oncology|May 25, 2006
Side effects of anti-cancer molecular-targeted therapies (not monoclonal antibodies)Gilberto de Castro, Ahmad Awada
Current Opinion in Oncology|April 9, 2014
The Cancer Genome Atlas findings in head and neck cancer: a renewed hopeGilberto de Castro, Marcelo Vailati Negrão
The Lancet. Oncology|January 4, 2006
Keynote comment: reimbursement for molecularly targeted anticancer agentsUmberto Tirelli, Gilberto de Castro, Ahmad Awada
International Journal of Radiation Oncology, Biology, Physics|March 5, 2013
In reply to OlsonGilberto de Castro, Igor Moisés Longo Snitcovsky
Current Opinion in Oncology|February 24, 2018
Patients' choices, quality of life and treatment selection in head and neck cancerMaria Perez Soares D'Alessandro, Gilberto de Castro
Current Opinion in Oncology|March 23, 2006
Evaluation, prevention and management of radiotherapy-induced xerostomia in head and neck cancer patientsGilberto de Castro, Miriam Hatsue Honda Federico
Pageof 16